Boston scientific closes acquisition of relievant medsystems, inc.

Recent healthcare plan coverage of intracept® system expands access to vertebrogenic pain treatment for tens of millions of patients marlborough, mass. , nov. 17, 2023 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced the close of its acquisition of relievant medsystems inc., a company that offers the only u.s. food and drug administration-cleared intracept® intraosseous nerve ablation system, a therapy to treat vertebrogenic pain that is a form of chronic low back pain.
BSX Ratings Summary
BSX Quant Ranking